CPIC 2026 | Conference Blueprint 2.0 Released: Who Is Co-organizing with Us?
Apr 28,2026
The 1st China Pharmaceutical Innovation Conference (CPIC), hosted by TONACEA, will be grandly held from July 22 to 24, 2026, at the National Exhibition and Convention Center (Shanghai).
This conference aims to establish a new paradigm of "China Innovation – Global Partnerships – Shanghai Dealmaking." It is not merely a showcase of cutting-edge technologies, but a strategic event dedicated to solidifying biopharmaceuticals as a national pillar industry and propelling Chinese innovative drugs onto the global stage. The conference is committed to achieving a deep synergy between innovation and finance, demonstrating China's R&D efficiency, expanding the global collaboration landscape, and significantly enhancing the international influence of Chinese innovative drugs.
Thousands of global industry leaders will gather in Shanghai Hongqiao, including representatives from regulatory agencies, multinational pharmaceutical companies, top-tier research institutes, leading biotech firms, international investment banks, professional investment institutions, commercial banks, stock exchanges, and renowned law and accounting firms. Through over 300 hot-topic sessions and high-frequency one-on-one targeted matchmaking, participants will collectively shape the future landscape of Chinese innovative drugs and medical devices.
As the "premier window" for overseas capital and enterprises to gain insight into China's innovation ecosystem, and the "core hub" for Chinese pharmaceutical companies to upgrade, go global, and connect with the world, the inaugural CPIC is set to become the definitive barometer for annual investment and collaboration in the global health industry.
Today, Conference Blueprint 2.0 is officially released. This is an open invitation to the global pharmaceutical industry to co-create. Who is co-organizing with us? It includes scientists bold enough to break new ground, visionary investors, law firms and investment banks active in global markets, and every fellow believer that "Chinese innovative drugs can change the world." July 2026, Shanghai Hongqiao – see you there!
Scan the QR code to register now!
Limited-time early bird tickets at 40% off – grab yours now!!
Conference Framework
✓ China’s Emerging Pillar Industry: A Global Compass
✓ Global Frontier of Biomedical Innovation
✓ The Road to MNC: Evolution of Chinese Pharmaceutical Enterprises
✓ FIC and World-Class Drug Development
✓ China’s R&D Efficiency and the Continuous Evolution of Innovative Drugs
✓ CPIC Major Announcements
✓ CPIC Award Ceremony
✓ CNS Innovation Drug Development Session(Co-hosted:Shanghai Kylinlab Biopartner Co, Ltd.，Beijing Quarkmed Technology Co., Ltd)
✓ ATMP & CGT Global Expansion Session
✓ Gene Therapy Innovation Session
✓ Stem Cell and Regenerative Medicine New Technology Session（Session Co-organizer: Vcanbio Cell & Gene Engineering Corp., Ltd.）
✓ Patient-Centric Stem Cell New Drug R&D Innovation Practice Session（Session Co-organizer: Guangzhou Cellgenes Biotechnology Co., Ltd.）
✓ Advanced Stem Cell Culture Technology Session（Co-hosted: Youyi Biotechnology Co., Ltd.）
✓ In Vivo CAR-T Innovation Session（Session Co-organizer: Juventas Cell Therapy Ltd.）
✓ Global Session on Small Nucleic Acid Drug Innovation（Session Co-organizers: Tofflon Science and Technology Group Co., Ltd., InnoStar, GemPharmatech, ChemPartner）
✓ Innovation and Future Trends in Antibody-Drug Conjugates
✓ New Molecular Entity Drug R&D Session（Co-hosted: WuXi AppTec）
✓ Molecular Glues and PROTACs Session
✓ Innovative Small Molecule Chemical Drugs Session
✓ Peptides and Novel Anti-Obesity Drugs Session
✓ Next-Generation Innovative Therapies Breakthrough Session（Session Co-organizers: BrightGene Bio-Medical Technology Co., Ltd., Laurel Venture Capital）
✓ Organoid and Biochip Session
✓ The Booming Radiopharmaceuticals Session
✓ Biosimilar Development Session
✓ Synthetic Biology Session（Co-hosted: Tianhui Capital）
✓ Novel Antibody Drug Development and Off‑Target Analysis Session
✓ AI and Intelligent Biopharmaceutical Manufacturing（Co-organized by: Huawei Pharmaceutical Business Unit）
✓ AI-Driven Drug Discovery Session（Session Co-organized by: MegaRobo & DP Technology）
✓ AI Healthcare Innovation Breakthroughs and Future Industry Landscape Session（Session Co-organized by: Marathon Venture Partners）
✓ AI Industrial Implementation in Innovative Drug R&D Session（Co-organized by: PhenoX）
✓ AI Reshaping the End-to-End Clinical R&D Session（Co-hosted by: JieNa Pharma）
✓ Global New Drug Review and Approval Trends Session
✓ Decree No. 818 and Translational Application of New Biomedical Technologies Session（Co-hosted: Tofflon Life Science）
✓ IIT Supervision Model and China’s Innovation Efficiency Session（Co-hosted: Canvest Bio）
✓ Biopharmaceutical IP Strategy and Tactics Session
✓ Bioprocessing and Smart Manufacturing Session（Co-hosted: Hanbon Technology）
✓ Co-building an Innovation Ecosystem for Biopharmaceutical Upstream Supply Chain Session（Co-hosted: Arios）
✓ Brain-Computer Interface Session （Session Co-organizers: TRIWISE International Capital Management Co., Ltd. , NeuroXess）
✓ Medical Device Innovation and Investment Session（Session Co-organizer: Proxima Ventures）
✓ Medical Device Global Expansion Session（Session Co-organizers: Southern California Association, Jiangsu Medphoenix Medical Technology Co.,Ltd.）
✓ International Advanced Drug Delivery Systems / Drug-Device Combinations Session（Organizer: ESCMedTech，Supporting Units: Wanhai Medical, Aptar Pharma）
✓ IPO Regulation and Listing Pathways Session
✓ The Evolution and Beyond of NewCo Session（Co-organizer: Biwo Investment Capital）
✓ Biomedical M&A Session（Co-hosted: Morning Whistle Group）
✓ Global Development of Pharmaceutical Companies and Emerging Market Cooperation Session（Co-hosted: Legend Capital & Rxilient）
✓ China Pharma's New Landscape of Belt and Road Global Expansion Session（Co-hosted: Merits & Tree Law Firm）
✓ Legal Safeguard and Value Empowerment for Globalization of Chinese Pharma Enterprises（Co-hosted: Fangda Partners）
✓ Vaccine Innovation and Global Expansion
✓ The Path to Advancing Global BD for Innovative Drugs and Ecosystem Restructuring Session
✓ New Drug Commercialization and Global Expansion Session
✓ Conference on Building a Cross‑border Biotech Innovation Ecosystem and a New Engine for Industrial Transformation
✓ Chinese Biotech: Integrated R&D-Production-Sales vs. Specialized Division of Labor
✓ Novel Drug Global Expansion from a VC Perspective
✓ New Models of Cross-Border Pharmaceutical Cooperation Session（Co-hosted by: JunHe Law Firm and Bank of Communications）
✓ China-US Cooperation Session（Co-organized by: GB-Partner）
✓ Leveraging China Innovation to Accelerate Global Drug R&D Session
✓ China-Europe Healthcare Industry Session（Co-hosted: GenOway）
✓ China-Japan Cooperation Session
✓ Hong Kong Global Opportunities Session（Co-hosted: Hong Kong Chinese Industry & Commerce Association, Hong Kong Bio-Med Innotech Association）
✓ Protheragen Session: Global Biomedical Cross-Border Transactions（Co-hosted: Protheragen）
✓ Innovative Transformation of Traditional Pharma Session
✓ Biomedical Industrial Park Ecosystem Development Session
✓ Research Translation and Early-stage Project Incubation Session
✓ USTC Original Innovation Power: Alumni Enterprise Innovation Matrix Session（Co-organized by: USTC Alumni）
✓ Women Leading the Future of Healthcare Innovation（Co-hosted: GB・Partner）
✓ Biomedical Industrial Park Tour Event
✓ Roadshow Session（Co-organized by: Bio-Link Capital）
✓ Pharmaceutical BD Team Building and Global Project Expansion Session
Follow or Contact Us
Follow the TONACEA Official WeChat Account and scan the QR code to register. Stay updated with the latest conference news.
Public Account QR Code
Registration QR Code
Conference Service Hotline
© 2026 TONACEA (Shanghai) Technology Development Co., Ltd. All rights reserved. All rights reserved.
